Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fang yi qing feng shi granules in Rheumatoid Arthritis
NCT02029599Phase 2Completed
- Sponsor
- Maoxiang Group Jilin Pharmacy Co. Ltd.
- Start
- Mar 2014
- Primary completion
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Fang yi qing feng shi granule in rheumatoid arthritis (RA), sponsored by Maoxiang Group Jilin Pharmacy Co. Ltd.. Started Mar 2014; status: completed.
02
Drugs
Fang yi qing feng shi granule
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT02029599.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02029599.